Botulinum toxin therapy in rehabilitative neurology;Botulinumtoxintherapie in der rehabilitationsneurologie

Nervenarzt

Volumn 67, Issue 8, 1996, Pages 686-694

  Dressler, D ^a,e   Argyrakis, A ^b   Schonle P W ^c   Wochnik, G ^d   Ruther E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Neurologie   (Germany)

^c Kliniken Schmieder   (Germany)

^d Waldklinik ^*

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Botulinum toxin; Dystonia; Rehabilitative neurology; Rigor; Spasms; Spasticity; Therapeutic use

Indexed keywords

BOTULINUM TOXIN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DYSTONIA; FEMALE; HUMAN; MUSCLE SPASM; PARESIS; RIGOR; SPASTICITY; TREATMENT OUTCOME;

ADULT; BOTULINUM TOXINS; COMBINED MODALITY THERAPY; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; NEUROMUSCULAR DISEASES; PHYSICAL THERAPY MODALITIES;

EID: 0029736896     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050042     Document Type: Article

References (19)

1. Ashworth B (1964) Preliminary trial of carisoprodol in multiple sclerosis. Practioner 192: 540-542
2. Borg-Stein J, Pine ZM, Miller JR, Brin MF (1993) Botulinum toxin for the treatment of spasticity in multiple sclerosis. Am J Phys Med Rehabil 72: 364-368
3. Dressler D (1994) Botulinum Toxin. Neue Indikationen. In: Poewe W (Hrsg) Neue Perspektiven für die Therapie mit Botulinum Toxin Typ A. Wissenschaftsverlag Wellingsbüttel, Hamburg, S 65-75
4. Dressler D (1994) Botulinum toxin: Is there a specific effect on dystonic muscle activity? Mov Disord 9: 284
5. Dressler D (1995) Grundlagen der Wirkung von Botulinumtoxin. In: Deuschl G (Hrsg) Botulinumtoxinforum 1995. Wissenschaftsverlag Wellingsbüttel, Hamburg, S14-30
6. Dressler D, Benecke R, Conrad B (1989) Botulinum-Toxin in der Therapie kraniozervikaler Dystonien. Nervenarzt 60: 386-394
7. Dunne JW, Heye N, Dunne SL (1995) Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 58: 232-235
8. Dykstra DD, Sidi AA (1990) Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 71: 24-26
9. Fahn S, Elton RL (1987) Members of the UPDRS Development Committee. In: Koller WC (ed) Handbook of Parkinson's disease. Dekker, New York
10. Grazko MA, Polo KB, Jabbari B (1995) Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 45: 712-717
11. Hesse S, Lücke D, Malezic M, Bertelt C, Friedrich H, Gregoric M, Mauritz KH (1994) Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 57: 1321-1324
12. Jankovic J, Schwartz K (1991) Botulinum toxin treatment of tremors. Neurology 41: 1185-1188
13. Konstanzer A, Ceballos-Baumann AO, Dressnandt J, Conrad B (1993) Lokale Injektionsbehandlung mit Botulinum-Toxin A bei schwerer Arm- und Beinspastik. Nervenarzt 64: 517-523
14. Medical Research Council (1976) Aids to the examination of the peripheral nervous system. Memorandum 45. HMSO, London
15. Memin B, Pollak P, Hommel M, Perret J (1992) Traitement de la spasticite par la toxine botulique. Rev Neurol Paris 148: 212-214
16. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990 (1991) Clinical use of botulinum toxin. Arch Neurol 48: 1294-1298
17. Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87: 1044-1049
18. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB (1990) Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 28: 512-515
19. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology (1990) Assessment: the clinical use of botulinum toxin-A in treating neurological disorders. Neurology 40: 1332-1336